Related Experiment Video
Updated: Dec 30, 2025

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
Published on: May 22, 2017
High density lipoprotein mimicking nanoparticles for atherosclerosis
Jun Chen1, Xixi Zhang1, Reid Millican1
1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
High-density lipoproteins (HDL) mimic nanoparticles offer promising therapeutic strategies for atherosclerosis, a leading cause of global mortality. This review highlights recent advancements in HDL-mimicking nanoparticles for imaging, targeting, and treating atherosclerosis.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Nanotechnology
Background:
- Atherosclerosis is a primary cause of global mortality, contributing to myocardial infarction, ischemic stroke, and peripheral arterial disease.
- High-density lipoproteins (HDL), or "good cholesterol", exhibit anti-atherosclerotic properties by facilitating cholesterol removal from plaque foam cells.
Purpose of the Study:
- To review recent progress in the development of HDL-mimicking nanoparticles (NPs).
- To summarize the applications of these HDL-mimicking NPs in imaging, targeting, and treating atherosclerosis.
Main Methods:
- Literature review of recent advancements in HDL-mimicking nanoparticle design.
- Analysis of studies focusing on the application of these nanoparticles in atherosclerosis.
Main Results:
- Significant progress has been made in designing functional HDL-mimicking NPs.
- These NPs show potential for various applications in atherosclerosis management.
Conclusions:
- HDL-mimicking NPs represent a promising therapeutic avenue for atherosclerosis.
- Further development and application of these NPs are crucial for combating cardiovascular disease.
Abstract:
Atherosclerosis is a major contributor to many cardiovascular events, including myocardial infarction, ischemic stroke, and peripheral arterial disease, making it the leading cause of death worldwide. High-density lipoproteins (HDL), also known as "good cholesterol", have been shown to demonstrate anti-atherosclerotic efficacy through the removal of cholesterol from foam cells in atherosclerotic plaques. Because of the excellent anti-atherosclerotic properties of HDL, in the past several years, there has been tremendous attention in designing HDL mimicking nanoparticles (NPs) of varying functions to image, target, and treat atherosclerosis. In this review, we are summarizing the recent progress in the development of HDL mimicking NPs and their applications for atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

